Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 2.72 g/t Au over 139.9 metres at Golden Summit (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > 7am est call really?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1022)
•••
Comment by Nailbiter2on Apr 02, 2023 11:51pm
116 Views
Post# 35375360

RE:7am est call really?

RE:7am est call really?Maybe void of call in. 

First NR.....

Analyst and Investor Call

Event Date: Thursday March 30, 2023
Time: 6:00 pm ET
Webcast Link: https://www.gowebcasting.com/12508

Participant Numbers:

Canada/USA TF: 1-800-319-4610
Toronto Toll: +1-416-915-3239

International Toll: +1-604-638-5340

------------------------------------------------

Second NR.....

Analyst and Investor Call

Event Date: Monday April 3, 2023
Time: 7:00 am ET
Webcast Link: https://www.gowebcasting.com/12508

NO PHONE NUMBER.
Gonna try Canada/USA TF: 1-800-319-4610
at 7am to see
 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities